ES502497A0 - Procedimiento de obtencion de preparados promotores de la coagulacion sanguinea - Google Patents

Procedimiento de obtencion de preparados promotores de la coagulacion sanguinea

Info

Publication number
ES502497A0
ES502497A0 ES502497A ES502497A ES502497A0 ES 502497 A0 ES502497 A0 ES 502497A0 ES 502497 A ES502497 A ES 502497A ES 502497 A ES502497 A ES 502497A ES 502497 A0 ES502497 A0 ES 502497A0
Authority
ES
Spain
Prior art keywords
promoters
procedure
blood coagulation
thrombin
substantially free
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES502497A
Other languages
English (en)
Other versions
ES8203609A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Cutter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22546793&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES502497(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cutter Laboratories Inc filed Critical Cutter Laboratories Inc
Publication of ES8203609A1 publication Critical patent/ES8203609A1/es
Publication of ES502497A0 publication Critical patent/ES502497A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ES502497A 1980-05-27 1981-05-26 Procedimiento de obtencion de preparados promotores de la coagulacion sanguinea Granted ES502497A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/153,341 US4364861A (en) 1980-05-27 1980-05-27 Blood-coagulation-promoting products and methods of preparing them

Publications (2)

Publication Number Publication Date
ES8203609A1 ES8203609A1 (es) 1982-04-01
ES502497A0 true ES502497A0 (es) 1982-04-01

Family

ID=22546793

Family Applications (1)

Application Number Title Priority Date Filing Date
ES502497A Granted ES502497A0 (es) 1980-05-27 1981-05-26 Procedimiento de obtencion de preparados promotores de la coagulacion sanguinea

Country Status (6)

Country Link
US (1) US4364861A (es)
EP (1) EP0041173B2 (es)
AT (1) ATE9354T1 (es)
CA (1) CA1170182A (es)
DE (1) DE3165965D1 (es)
ES (1) ES502497A0 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404132A (en) * 1980-05-27 1983-09-13 Cutter Laboratories, Inc. Blood coagulation promoting product
AT368883B (de) * 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
USRE32011E (en) * 1981-12-14 1985-10-22 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4495175A (en) * 1982-08-05 1985-01-22 University Of Rochester Preparation of highly purified human antihemophilic factor
DE3336631A1 (de) * 1983-10-08 1985-04-18 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von plasma oder von konzentraten der blutgerinnungsfaktoren ii, vii, ix und x
US5149787A (en) * 1984-05-22 1992-09-22 The Blood Center Research Foundation Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US4710381A (en) * 1984-05-22 1987-12-01 The Blood Center Of Southeastern Wisconsin Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
GB2178533B (en) * 1985-07-22 1989-07-19 Asahi Chemical Ind Analytical method of enzyme precursors and device therefor
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
US4725673A (en) * 1986-08-29 1988-02-16 Alpha Therapeutic Corporation Plasma fraction purification using silica resin bound to a ligand
DE3843126C3 (de) * 1988-12-22 1994-10-06 Octapharma Ag Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates
AT398079B (de) * 1991-11-04 1994-09-26 Immuno Ag Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
UA97234C2 (ru) 2005-11-01 2012-01-25 Уайєт Раствор хлорида натрия для восстановления влагосодержания композиции лиофилизированного фактора ix
RU2559576C1 (ru) * 2014-06-09 2015-08-10 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения РФ Способ получения вирусбезопасного полного протромбинового комплекса
FR3026644B1 (fr) * 2014-10-07 2018-01-05 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Colle biologique et son utilisation comme medicament
CN105440127B (zh) * 2015-12-30 2018-10-16 上海莱士血液制品股份有限公司 一种以人血浆Cohn组分III为原料的FEIBA的制备方法
RU2648517C1 (ru) * 2017-06-23 2018-03-26 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения Российской Федерации (ФГБУ ГНЦ Минздрава России) Способ получения лиофилизированного препарата активированного протромбинового комплекса, обладающего фактор viii-шунтирующей активностью
CN118460516B (zh) * 2024-05-28 2025-10-28 成都协和生物技术有限责任公司 一种活化凝血酶原复合物aPCC及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3717708A (en) * 1968-10-24 1973-02-20 Cutter Lab Blood coagulation complex
US3560475A (en) * 1969-06-19 1971-02-02 Baxter Laboratories Inc Prothrombin complex prepared by precipitation with polyethylene glycol
US3682881A (en) * 1970-10-02 1972-08-08 Baxter Laboratories Inc Fractionation of plasma using glycine and polyethylene glycol
DE2459291C3 (de) * 1974-12-14 1981-06-04 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines antihämophiles Globulin A enthaltenden Konzentrats neben einem Prothrombin- Komplex und einer Lösung von lagerstabilen Serumproteinen
US4170590A (en) * 1974-12-14 1979-10-09 Biotest-Serum-Institut Gmbh Ion exchanger treatment of citrate-stabilized plasma
US4056222A (en) * 1975-08-25 1977-11-01 Focke & Pfuhl Compartmentalized structure with pivotable separating webs
SE405549B (sv) * 1975-10-09 1978-12-18 Pharmacia Fine Chemicals Ab Forfarande for isolering av albumin ur plasmaprodukter genom kromatografisk fraktionering
AT350726B (de) * 1976-08-30 1979-06-11 Immuno Ag Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen

Also Published As

Publication number Publication date
US4364861A (en) 1982-12-21
ATE9354T1 (de) 1984-09-15
ES8203609A1 (es) 1982-04-01
DE3165965D1 (en) 1984-10-18
EP0041173B2 (en) 1992-11-11
EP0041173A1 (en) 1981-12-09
EP0041173B1 (en) 1984-09-12
CA1170182A (en) 1984-07-03

Similar Documents

Publication Publication Date Title
ES502497A0 (es) Procedimiento de obtencion de preparados promotores de la coagulacion sanguinea
FR2679251B1 (fr) Procede de preparation d'un concentre de thrombine humaine destine a un usage therapeutique.
DE3379644D1 (en) Adsorbent and process for preparing the same
ZA851368B (en) Skin treatment product
CY1737A (en) Desulfatohirudine process for its preparation and pharmaceutical agent
NZ210427A (en) Process for purifying blood clotting factor (factor viii:c); pharmaceutical compositions
EP0124506A3 (en) Method of inactivating pathogens
GB8824869D0 (en) Synthetic antibody
SE8009157L (sv) Sett att framstellning hogrenade koncentrat av protrombinkomplex, de erhallna koncentraten och framstellning derav
DE3570041D1 (en) Method for inactivating filterable pathogens
IT1177889B (it) Proteine umane,antisieri per esse,procedimento per prepararli e corre di di prova che li contengono
GB1527268A (en) Antiserum for the quantitative determination of the decomposition products x and y of fibrin and fibrinogen
DK241684D0 (da) Fremgangsmaade til fremstilling af et antithrombin iii-heparin-eller antithrombin iii-heparinoidkoncentrat
SE7607077L (sv) Belagt perlformigt aktivt kol for rening av blod
ATE76751T1 (de) Verfahren zur isolierung des blutgerinnungsfaktors ix.
ES502498A0 (es) Procedimiento para preparar un complejo de coagulacion san- guinea
DE3170001D1 (en) Method for the production of an antithrombin-heparin complex and pharmaceutical compositions containing the complex
ES8405621A1 (es) Una inmunopreparacion tumoral.
DK0499679T3 (da) Terapeutisk middel til diabetisk gangræn
ZA817395B (en) 1-carboxyalkanoylindoline-2-carboxylic acids,process for their manufacture,pharmaceutical preparations containing these compounds and their therapeutic application
ZA817559B (en) 1-carboxy-azaalkanoylindoline-2-carboxylic acids,process for their manufacture,pharmaceutical preparations containing these compounds and their therapeutic application
JPS5229293A (en) Reagent for determination of alkali-phosphatase activity
GEP19991402B (en) Method of treatment of tube sterility of an inflammatory genesis

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20020206